The study was designed as proof of concept for NNMT as a drug-development target
Amylin Is Making a Comeback: Why This Forgotten Hormone Is Back in the Spotlight 3 weeks ago Articles, Diabetes, GLP- 1 Agonist Therapy Center, Obesity, Therapies, Type 2 Diabetes, Type 2 Diabetes 1,619 views For years, glucagon-like peptide-1 (GLP-1) receptor agonists have dominated conversations about diabetes and obesity treatment
If it has a role, its more like a supporting actor than a lead therapy
10.3390/nu10101537 71 LiuY.TranD
This paradoxically indicates that the peptide is active, though it can be inconvenient
Hes passionate about simplifying complex health topics and helping men get stronger, leaner, and healthierespecially those facing stress, hormone challenges, or genetic roadblocks like MTHFR.What youll learn in this episode: How stress and cortisol affect energy, hormones, and performance Why fatigue is often a sign of deeper health issues Practical strategies to restore balance and vitality How lifestyle habits and functional approaches can transform mens healthDisclaimer:The views and opinions expressed by guests featured in EllieMDs social media videos are solely those of the individuals involved and do not necessarily reflect EllieMDs views or opinions